Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Mary Beth McCarville"'
Autor:
David Cullins, Barbara Rooney, Natasha Sahr, April Sykes, Mary Beth McCarville, Sara M Federico, Amanda Sooter, William E Janssen, Gwendolyn Anthony, Michael A Dyer, Alberto S Pappo, Wing H Leung, Wayne L Furman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundNatural killer (NK) cells are one of the main effector populations of immunotherapy with monoclonal antibody and cytokines, used in combination with chemotherapy to treat children with high-risk neuroblastoma on this phase II trial. However
Externí odkaz:
https://doaj.org/article/61aa4de3291f4f04b11f55638ec3891c
Autor:
Alberto S. Pappo, Wing H. Leung, Paul M. Sondel, Stephen D. Gillies, Jacquelyn Hank, Alice L. Yu, Gwendolyn Anthony, Armita Bahrami, Victor M. Santana, Brandon Triplett, Fariba Navid, Elizabeth Stewart, Sara Helmig, Michael William Bishop, Rachel C. Brennan, Jianrong Wu, April Sykes, Natasha Sahr, Matthew J. Krasin, Andrew M. Davidoff, Barry L. Shulkin, Mary Beth McCarville, Sara M. Federico, Wayne L. Furman
Tables of antibody infusion times and Curie Scores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08e3667ff7c24f7833bdbcdc55635118
https://doi.org/10.1158/1078-0432.22471796.v1
https://doi.org/10.1158/1078-0432.22471796.v1
Autor:
Alberto S. Pappo, Wing H. Leung, Paul M. Sondel, Stephen D. Gillies, Jacquelyn Hank, Alice L. Yu, Gwendolyn Anthony, Armita Bahrami, Victor M. Santana, Brandon Triplett, Fariba Navid, Elizabeth Stewart, Sara Helmig, Michael William Bishop, Rachel C. Brennan, Jianrong Wu, April Sykes, Natasha Sahr, Matthew J. Krasin, Andrew M. Davidoff, Barry L. Shulkin, Mary Beth McCarville, Sara M. Federico, Wayne L. Furman
Purpose:We sought to evaluate whether combining a humanized antidisialoganglioside mAb (hu14.18K322A) with induction chemotherapy improves early responses and outcomes in children with newly diagnosed high-risk neuroblastoma.Patients and Methods:We c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c02c827012f74d0ab16f6920cb4e073d
https://doi.org/10.1158/1078-0432.c.6528014.v1
https://doi.org/10.1158/1078-0432.c.6528014.v1
Autor:
Mary Beth McCarville, Victor M. Santana, Elizabeth Stewart, Armita Bahrami, Rachel C. Brennan, Clinton F. Stewart, Wayne L. Furman, Sara Helmig, Michael W. Bishop, Jessica Gartrell, April Sykes, Alberto S. Pappo, Michael R. Clay, Kimberly Godwin, Sue C. Kaste, Olivia Campagne, Sara M. Federico, Natasha Sahr, Anang A. Shelat, Dana Hawkins
Publikováno v:
European Journal of Cancer. 137:204-213
Background Talazoparib combined with irinotecan and temozolomide demonstrated efficacy in a murine Ewing sarcoma model. Based on these data, we conducted a phase I trial of talazoparib and irinotecan with/without temozolomide in paediatric patients w
Autor:
Vinay M. Daryani, Andrew M. Davidoff, Wayne L. Furman, Jianrong Wu, Clinton F. Stewart, Sara M. Federico, Alberto S. Pappo, Kenneth J. Caldwell, Mary Beth McCarville, Victor M. Santana, Fariba Navid, Shenghua Mao
Publikováno v:
Eur J Cancer
Background Angiogenesis is critical for tumour growth and metastasis. Dual inhibition of vascular endothelial growth factors and platelet-derived growth factor receptors suppresses angiogenesis. This expansion cohort of a phase I study targeted angio
Autor:
Wayne L. Furman, Fariba Navid, Wing Leung, Alice L. Yu, Matthew J. Krasin, Alberto S. Pappo, Gwendolyn Anthony, Barry L. Shulkin, Armita Bahrami, Stephen D. Gillies, Victor M. Santana, Mary Beth McCarville, Elizabeth Stewart, Michael W. Bishop, Jacquelyn A. Hank, Sara M. Federico, Paul M. Sondel, Rachel C. Brennan, Natasha Sahr, Jianrong Wu, Sara Helmig, April Sykes, Andrew M. Davidoff, Brandon M. Triplett
Publikováno v:
Clin Cancer Res
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 21
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 21
Purpose: We sought to evaluate whether combining a humanized antidisialoganglioside mAb (hu14.18K322A) with induction chemotherapy improves early responses and outcomes in children with newly diagnosed high-risk neuroblastoma. Patients and Methods: W
Autor:
Andrea Hayes-Jordan, Rose Anne Speights, Jennifer O. Black, Karen Morano, Suzanne L. Wolden, Carol D. Morris, Fran Laurie, Simon C. Kao, Sheri L. Spunt, R. Lor Randall, James R. Anderson, Lynn Million, Thomas J. Fitzgerald, Mary Beth McCarville, Torunn I. Yock, Douglas S. Hawkins, Sarah S. Donaldson, Stephanie A. Terezakis, Yueh Yun Chi, David A. Rodeberg, Cheryl M. Coffin
Publikováno v:
Int J Radiat Oncol Biol Phys
International journal of radiation oncology, biology, physics, vol 110, iss 3
International journal of radiation oncology, biology, physics, vol 110, iss 3
PurposeThe ARST0332 trial for pediatric and young adults with nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) used risk-based treatment including primary resection with lower-than-standard radiation doses to optimize local control (LC) while minimizi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd61ca3a32111c7ce830791751edfb7
https://europepmc.org/articles/PMC8767764/
https://europepmc.org/articles/PMC8767764/
Autor:
Mary Beth McCarville, Alberto S. Pappo, Barbara Rooney, William E. Janssen, Gwendolyn Anthony, April Sykes, Sara M. Federico, Amanda Sooter, Natasha Sahr, Michael A. Dyer, Wayne L. Furman, Brandon M. Triplett, Rosa Nguyen, Wing Leung, Aimee C Talleur, David Cullins
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundNatural killer (NK) cells are one of the main effector populations of immunotherapy with monoclonal antibody and cytokines, used in combination with chemotherapy to treat children with high-risk neuroblastoma on this phase II trial. However
Autor:
Mary Beth McCarville, Wayne L. Furman, Marcio H. Malogolowkin, Sarangarajan Ranganathan, Gregory M. Tiao, Stephen P. Dunn, Milton J. Finegold, Caihong Xia, Carlos Rodriguez-Galindo, Rebecka L. Meyers, Max R Langham, Allison F. O'Neill, Muna Qayed, Alexander J. Towbin, Mark Krailo, Eugene D. McGahren, Howard M. Katzenstein
Publikováno v:
The Lancet. Oncology. 20(5)
Summary Background Hepatoblastoma treatment with curative intent requires surgical resection, but only about a third of newly diagnosed patients with hepatoblastoma have resectable disease at diagnosis. Patients who have upfront resection typically r
Autor:
David M. Parham, Carola A.S. Arndt, Jeannine S. McCune, Carol D. Morris, Douglas S. Hawkins, James R. Anderson, Sarah S. Donaldson, Geoff McCowage, Lynn Million, Torunn I. Yock, Lisa Bomgaars, Yueh Yun Chi, Andrea Hayes-Jordan, Leo Mascarenhas, Mary Beth McCarville, Sheri L. Spunt, William H. Meyer, Jing Tian, Stephen X. Skapek, David A. Rodeberg, Suzanne L. Wolden, Lisa A. Teot, Erin R. Rudzinski, Margarett Shnorhavorian
Purpose Intermediate-risk rhabdomyosarcoma (RMS) includes patients with either nonmetastatic, unresected embryonal RMS (ERMS) with an unfavorable primary site or nonmetastatic alveolar RMS (ARMS). The primary aim of this study was to improve the outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ca4d76559f6c6d8bf8c8c2355dd587
https://europepmc.org/articles/PMC6145831/
https://europepmc.org/articles/PMC6145831/